---
title: "WHO guidelines expose gaps in care for children and adolescents with obesity"
id: "nature-0-young-people-with-obesity-deserve-better-care"
canonical_url: "https://medichelpline.com/clinical-feed/nature-0-young-people-with-obesity-deserve-better-care"
content_type: "clinical_feed_article"
specialty: "Pediatrics"
source_name: "Nature Medicine"
source_url: "https://www.nature.com/articles/s41591-026-04784-x"
published_at: "2026-11-12T12:00:00.000Z"
evidence_level: "Journal Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# WHO guidelines expose gaps in care for children and adolescents with obesity
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/nature-0-young-people-with-obesity-deserve-better-care
- **Specialty:** [Pediatrics](https://medichelpline.com/clinical-feed/pediatrics.md)
- **Primary Source:** Nature Medicine
- **Source URL:** [Original Journal Publication](https://www.nature.com/articles/s41591-026-04784-x)
- **Published At:** 2026-11-12T12:00:00.000Z
- **Evidence Rating:** Journal Feed
## Executive GIST (TL;DR)
- The World Health Organization published its first global guidelines on child and adolescent obesity on 7 October 2026, covering children under 10 and adolescents aged 10–19; the guidelines do not recommend routine pharmacological treatment in young children and advise drug use in adolescents only after other options are exhausted. - Evidence supporting **pharmacotherapy** for young people is limited; the guideline panels judged the evidence base for drugs as low, and for lifestyle interventions such as diet and exercise as very low. - Global prevalence of adolescent overweight rose from about 8% in 1990 to roughly 20% in 2024, indicating rising burden despite adult trends stabilizing with wider drug access. - Longitudinal data indicate persistence: around 70% of adolescents with obesity remain with obesity by age 30, linking early-life obesity to later chronic disease risks including type 2 diabetes and chronic kidney disease. - Children with obesity face immediate medical risks (oral disease, asthma, hypertension, pediatric autoimmune disorders), plus psychosocial harms such as stigma, depression and reduced educational attainment. - Structural drivers matter: sedentary lifestyles, high-fat and high-sugar food environments, lower socioeconomic status and parental obesity are implicated; randomized trials often fail to replicate real-world constraints like limited safe exercise spaces and food affordability. - Trials of exercise and dietary interventions need better ecological validity; programs that target the adults responsible for a child’s diet (parents, carers, schools) are necessary but under-researched. - For **GLP-1RAs**, available adult evidence shows weight regain on cessation; this raises the prospect that pediatric initiation could commit individuals to long-term or lifelong treatment, with unknown developmental safety signals and risks of misuse outside medical oversight. - Outstanding clinical questions include long-term safety through puberty, durability of benefit in adolescents, management strategies for cessation of drugs started in childhood, and the impact of pharmacotherapy availability on eating disorders and body image in youth.
## Clinical Analysis & Structured Key Points
## Your privacy, your choice We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media, as well as to allow video information to be shared for both marketing, analytics and editorial purposes. By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection. See our [privacy policy](https://www.nature.com/info/privacy) for more information on the use of your personal data. Manage preferences for further information and to change your choices. Accept all cookies Reject optional cookies [Skip to main content](https://www.nature.com/articles/s41591-026-04784-x#content) Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript. Advertisement [ ![Nature Medicine](https://media.springernature.com/full/nature-cms/uploads/product/nm/header-95e59e63930e5d6009bad2c23a42ab2d.svg) ](https://www.nature.com/nm) * [ View all journals ](https://www.nature.com/siteindex) * [ Saved research ](https://www.nature.com/saved-research) * [ Search ](javascript:;) ## Search Search articles by subject, keyword or author Show results from All journals This journal Search [ Advanced search ](https://www.nature.com/search/advanced) ### Quick links * [Explore articles by subject](https://www.nature.com/subjects) * [Find a job](https://www.nature.com/naturecareers) * [Guide to authors](https://www.nature.com/authors/index.html) * [Editorial policies](https://www.nature.com/authors/editorial_policies/) * [Log in](https://idp.nature.com/auth/personal/springernature?redirect_uri=https://www.nature.com/articles/s41591-026-04784-x) * [ Content Explore content ](javascript:;) ## Explore content * [ Research articles ](https://www.nature.com/nm/research-articles) * [ Reviews & Analysis ](https://www.nature.com/nm/reviews-and-analysis) * [ News & Comment ](https://www.nature.com/nm/news-and-comment) * [ Podcasts ](https://www.nature.com/nm/podcast) * [ Current issue ](https://www.nature.com/nm/current-issue) * [ Collections ](https://www.nature.com/nm/collections) * [Follow us on Facebook ](https://www.facebook.com/Nature-Medicine-193691346949/) * [Follow us on X ](https://twitter.com/naturemedicine) * [Sign up for alerts ](https://journal-alerts.springernature.com/subscribe?journal_id=41591) * [ RSS feed ](https://www.nature.com/nm.rss) * [ About the journal ](javascript:;) ## About the journal * [ Aims & Scope ](https://www.nature.com/nm/aims) * [ Journal Information ](https://www.nature.com/nm/journal-information) * [ Editors ](https://www.nature.com/nm/editors) * [ Journal Metrics ](https://www.nature.com/nm/journal-impact) * [ Research Cross-Journal Editorial Team ](https://www.nature.com/nm/research-cross-journal-editorial-team) * [ Reviews Cross-Journal Editorial Team ](https://www.nature.com/nm/reviews-cross-journal-editorial-team) * [ Statistical Advisory Panel ](https://www.nature.com/nm/statistics-advisory-panel) * [ Our publishing models ](https://www.nature.com/nm/our-publishing-models) * [ Editorial Values Statement ](https://www.nature.com/nm/editorial-values-statement) * [ Editorial Policies ](https://www.nature.com/nm/editorial-policies) * [ Content Types ](https://www.nature.com/nm/content) * [ Web Feeds ](https://www.nature.com/nm/web-feeds) * [ Contact ](https://www.nature.com/nm/contact) * [ Publish with us ](javascript:;) ## Publish with us * [ Submission Guidelines ](https://www.nature.com/nm/submission-guidelines) * [ For Reviewers ](https://www.nature.com/nm/for-reviewers) * [ Language editing services ](https://authorservices.springernature.com/go/sn/?utm_source=For+Authors&utm_medium=Website_Nature&utm_campaign=Platform+Experimentation+2022&utm_id=PE2022) * [Open access funding](https://www.nature.com/nm/open-access-funding) * [Submit manuscript ](https://mts-nmed.nature.com/cgi-bin/main.plex) * [ Sign up for alerts ](https://journal-alerts.springernature.com/subscribe?journal_id=41591) * [ RSS feed ](https://www.nature.com/nm.rss) 1. [nature](https://www.nature.com/) 2. [nature medicine](https://www.nature.com/nm) 3. [editorials](https://www.nature.com/nm/articles?type=editorial) 4. article Young people with obesity deserve better care [ Download PDF ](https://www.nature.com/articles/s41591-026-04784-x.pdf) [ Download PDF ](https://www.nature.com/articles/s41591-026-04784-x.pdf) * Editorial * Published: 12 November 2026 # Young people with obesity deserve better care [_Nature Medicine_](https://www.nature.com/nm) (2026) [Cite this article](https://www.nature.com/articles/s41591-026-04784-x#citeas) Save article [ View saved research ](https://www.nature.com/saved-research) The evidence available to support the treatment of obesity in children and adolescents is insufficient and requires rapid improvement. On 7 October 2026, the World Health Organization released its [first guidelines](https://www.who.int/news/item/07-10-2026-who-issues-first-global-guidelines-on-child-and-adolescent-obesity) for the treatment of obesity among children under 10 years of age and adolescents (10–19 years of age). The guidelines do not recommend pharmacological treatment such as glucagon-like peptide-1 receptor agonists (GLP-1RAs) in children. In adolescents, the guidelines recommend pharmaceutical intervention only after exhaustion of other treatment options. The evidence bases for pharmacotherapy and more traditional weight-loss interventions (such as exercise or diet) are rated as low and very low, respectively. The guidelines, although useful and much needed, highlight a litany of evidence gaps that need filling. Addressing obesity in children and adolescents is an unmet need. Although the rates of obesity are slowing in adults with access to drugs such as GLP-1RAs, no such trend has been seen in children. In 1990, for instance, 8% of adolescents worldwide were overweight. In 2024, that figure [had increased to 20%](https://www.who.int/news-room/questions-and-answers/item/noncommunicable-diseases-childhood-overweight-and-obesity). Obesity in youth is likely to persist into adulthood. For instance, 70% of adolescents with obesity are still with obesity at 30 years of age[1](https://www.nature.com/articles/s41591-026-04784-x#ref-CR1 "Simmonds, M., Llewellyn, A., Owen, C. G. & Woolacott, N. Obes. Rev. 17, 95–107 \(2016\)."). Obesity is associated with long-term conditions such as chronic kidney diseases and type 2 diabetes. Such chronic illnesses can take many years to manifest, but obesity also poses a risk to children in the immediate term. Children with obesity are at greater risk of poor oral health, asthma, hypertension and even pediatric autoimmune disorders than are children without obesity. They also face stigma that leads to depression and decreased educational attainment[2](https://www.nature.com/articles/s41591-026-04784-x#ref-CR2 "Marcus, C., Danielsson, P. & Hagman, E. J. Intern. Med. 292, 870–891 \(2022\)."). The rising trends of young people with obesity can be explained by increasingly sedentary lifestyles, combined with increased uptake of high-fat and high-sugar foods. Subtler causes of childhood obesity include lower socioeconomic status[3](https://www.nature.com/articles/s41591-026-04784-x#ref-CR3 "Li, M., Gong, W., Wang, S. & Li, Z. BMJ Open 12, e065425 \(2022\).") and having parents with obesity[4](https://www.nature.com/articles/s41591-026-04784-x#ref-CR4 "Lee, J. S., Jin, M. H. & Lee, H. J. Clin. Exp. Pediatr. 65, 35–46 \(2021\)."). It is this complexity of interactions that causes common-sense recommendations to fail. Physical activity for a child with obesity is possible only if that child lives in an area where they can easily exercise. The ‘sanitized’ environments of randomized controlled trials, including investigating personal providing advice, are unlikely to be replicable in real world conditions, such as youths who live in dense urban environments with limited exercise space and high air pollution. Future exercise research must be better modeled on where young people actually are. Dietary intervention studies face similar hurdles. Dietary advice is useful only if the individual, or their parents or carers, can afford or have access to healthy food. Government programs, such as prescribing food vouchers, can support those struggling to afford healthy food and have been found to have health benefits[5](https://www.nature.com/articles/s41591-026-04784-x#ref-CR5 "Hager, K. et al. Nat. Med. 32, 2147–2154 \(2026\)."). These benefits, however, have not yet been investigated for children, who are seldom responsible for the food they eat. Interventions for tackling obesity in children must also incorporate how to empower those responsible for a child’s diet (whether they are parents, guardians or schoolteachers). Given the impact of GLP-1RAs in the treatment of adults with obesity, it is sensible to consider the possibility that these drugs may offer benefits for children. However, the evidence base for (or against) their use in this group is lagging behind. For adolescents, for whom their conditional use has been recommended, the evidence for GLP-1RAs also remains limited. It will not be sufficient to only collect information on efficacy in younger people; it is possible that safety signals differ between this population and adults. Long-term follow-up will be needed to ensure that pharmacotherapy, for instance, does not interfere with the development that occurs during puberty. Current evidence suggests that cessation of GLP-1RAs leads to weight regain in adults[6](https://www.nature.com/articles/s41591-026-04784-x#ref-CR6 "Horn, D. B., Aronne, L. J. & Wharton, S. Lancet 407, 2305–2318 \(2026\)."), which means that to treat obesity, GLP-1RAs will probably be lifelong medications. Therefore, starting GLP-1RA medication in childhood could lead to that child’s remaining on the medication for life. As that child grows, they may wish to stop taking the medication, for instance, owing to gastrointestinal side effects or simply an inability to access the medication. Healthcare systems will need to develop strategies for managing patients who are ending their use of GLP-1RAs in adulthood, possibly without ever having had to manage their weight without pharmacological assistance. There is also the danger that access to GLP-1RAs without medical oversight could lead to their abuse among young people. Those investigating eating disorders and body dysmorphia would need to consider the effect that normalization of GLP-1RA use in children would have on these conditions. There is an urgent need to address obesity in children and adolescents. Children find themselves in a complex obesogenic environment that prioritizes high-fat ultra-processed food over healthier alternatives. It is also an environment whose construction they had little say in. Young people at the very least deserve treatment options informed by evidence that fully takes into account the complexity of the world they are growing up in. ## References 1. Simmonds, M., Llewellyn, A., Owen, C. G. & Woolacott, N. _Obes. Rev._ **17** , 95–107 (2016). [Article](https://doi.org/10.1111%2Fobr.12334) [CAS](https://www.nature.com/articles/cas-redirect/1:STN:280:DC%2BC28rktVSnsA%3D%3D) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26696565) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=&journal=Obes.%20Rev.&doi=10.1111%2Fobr.12334&volume=17&pages=95-107&publication_year=2016&author=Simmonds%2CM&author=Llewellyn%2CA&author=Owen%2CCG&author=Woolacott%2CN) 2. Marcus, C., Danielsson, P. & Hagman, E. _J. Intern. Med._ **292** , 870–891 (2022). [Article](https://doi.org/10.1111%2Fjoim.13547) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=35883220) [PubMed Central](http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805112) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=&journal=J.%20Intern.%20Med.&doi=10.1111%2Fjoim.13547&volume=292&pages=870-891&publication_year=2022&author=Marcus%2CC&author=Danielsson%2CP&author=Hagman%2CE) 3. Li, M., Gong, W., Wang, S. & Li, Z. _BMJ Open_ **12** , e065425 (2022). [Article](https://doi.org/10.1136%2Fbmjopen-2022-065425) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=36526312) [PubMed Central](http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764609) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=&journal=BMJ%20Open&doi=10.1136%2Fbmjopen-2022-065425&volume=12&publication_year=2022&author=Li%2CM&author=Gong%2CW&author=Wang%2CS&author=Li%2CZ) 4. Lee, J. S., Jin, M. H. & Lee, H. _J. Clin. Exp. Pediatr._ **65** , 35–46 (2021). [Article](https://doi.org/10.3345%2Fcep.2020.01620) [PubMed Central](http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743427) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=&journal=J.%20Clin.%20Exp.%20Pediatr.&doi=10.3345%2Fcep.2020.01620&volume=65&pages=35-46&publication_year=2021&author=Lee%2CJS&author=Jin%2CMH&author=Lee%2CH) 5. Hager, K. et al. _Nat. Med._ **32** , 2147–2154 (2026). [Article](https://doi.org/10.1038%2Fs41591-026-04407-5) [CAS](https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB28XhsVSjt7fE) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=42230753) [PubMed Central](http://www.ncbi.nlm.nih.gov/pmc/articles/PMC13279258) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=&journal=Nat.%20Med.&doi=10.1038%2Fs41591-026-04407-5&volume=32&pages=2147-2154&publication_year=2026&author=Hager%2CK) 6. Horn, D. B., Aronne, L. J. & Wharton, S. _Lancet_ **407** , 2305–2318 (2026). [Article](https://doi.org/10.1016%2FS0140-6736%2826%2900656-2) [CAS](https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB28Xht1Witb7J) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=42119587) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=&journal=Lancet&doi=10.1016%2FS0140-6736%2826%2900656-2&volume=407&pages=2305-2318&publication_year=2026&author=Horn%2CDB&author=Aronne%2CLJ&author=Wharton%2CS) [Download references](https://citation-needed.springer.com/v2/references/10.1038/s41591-026-04784-x?format=refman&flavour=references) ## Rights and permissions [Reprints and permissions](https://s100.copyright.com/AppDispatchServlet?title=Young%20people%20with%20obesity%20deserve%20better%20care&author=&contentID=10.1038%2Fs41591-026-04784-x&copyright=Springer%20Nature%20America%2C%20Inc.&publication=1078-8956&publicationDate=2026-11-12&publisherName=SpringerNature&orderBeanReset=true) ## About this article [![Check for updates. Verify currency and authenticity via CrossMark](https://www.nature.com/articles/s41591-026-04784-x)](https://crossmark.crossref.org/dialog/?doi=10.1038/s41591-026-04784-x) ### Cite this article Young people with obesity deserve better care. _Nat Med_ (2026). https://doi.org/10.1038/s41591-026-04784-x [Download citation](https://citation-needed.springer.com/v2/references/10.1038/s41591-026-04784-x?format=refman&flavour=citation) * Published: 12 November 2026 * Version of record: 12 November 2026 * DOI: https://doi.org/10.1038/s41591-026-04784-x ### Share this article Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy shareable link to clipboard Provided by the Springer Nature SharedIt content-sharing initiative [ Download PDF ](https://www.nature.com/articles/s41591-026-04784-x.pdf) * Sections * References * [References](https://www.nature.com/articles/s41591-026-04784-x#Bib1) * [Rights and permissions](https://www.nature.com/articles/s41591-026-04784-x#rightslink) * [About this article](https://www.nature.com/articles/s41591-026-04784-x#article-info) Advertisement 1. Simmonds, M., Llewellyn, A., Owen, C. G. & Woolacott, N. _Obes. Rev._ **17** , 95–107 (2016). [Article](https://doi.org/10.1111%2Fobr.12334) [CAS](https://www.nature.com/articles/cas-redirect/1:STN:280:DC%2BC28rktVSnsA%3D%3D) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26696565) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=&journal=Obes.%20Rev.&doi=10.1111%2Fobr.12334&volume=17&pages=95-107&publication_year=2016&author=Simmonds%2CM&author=Llewellyn%2CA&author=Owen%2CCG&author=Woolacott%2CN) 2. Marcus, C., Danielsson, P. & Hagman, E. _J. Intern. Med._ **292** , 870–891 (2022). [Article](https://doi.org/10.1111%2Fjoim.13547) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=35883220) [PubMed Central](http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805112) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=&journal=J.%20Intern.%20Med.&doi=10.1111%2Fjoim.13547&volume=292&pages=870-891&publication_year=2022&author=Marcus%2CC&author=Danielsson%2CP&author=Hagman%2CE) 3. Li, M., Gong, W., Wang, S. & Li, Z. _BMJ Open_ **12** , e065425 (2022). [Article](https://doi.org/10.1136%2Fbmjopen-2022-065425) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=36526312) [PubMed Central](http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764609) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=&journal=BMJ%20Open&doi=10.1136%2Fbmjopen-2022-065425&volume=12&publication_year=2022&author=Li%2CM&author=Gong%2CW&author=Wang%2CS&author=Li%2CZ) 4. Lee, J. S., Jin, M. H. & Lee, H. _J. Clin. Exp. Pediatr._ **65** , 35–46 (2021). [Article](https://doi.org/10.3345%2Fcep.2020.01620) [PubMed Central](http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743427) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=&journal=J.%20Clin.%20Exp.%20Pediatr.&doi=10.3345%2Fcep.2020.01620&volume=65&pages=35-46&publication_year=2021&author=Lee%2CJS&author=Jin%2CMH&author=Lee%2CH) 5. Hager, K. et al. _Nat. Med._ **32** , 2147–2154 (2026). [Article](https://doi.org/10.1038%2Fs41591-026-04407-5) [CAS](https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB28XhsVSjt7fE) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=42230753) [PubMed Central](http://www.ncbi.nlm.nih.gov/pmc/articles/PMC13279258) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=&journal=Nat.%20Med.&doi=10.1038%2Fs41591-026-04407-5&volume=32&pages=2147-2154&publication_year=2026&author=Hager%2CK) 6. Horn, D. B., Aronne, L. J. & Wharton, S. _Lancet_ **407** , 2305–2318 (2026). [Article](https://doi.org/10.1016%2FS0140-6736%2826%2900656-2) [CAS](https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB28Xht1Witb7J) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=42119587) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=&journal=Lancet&doi=10.1016%2FS0140-6736%2826%2900656-2&volume=407&pages=2305-2318&publication_year=2026&author=Horn%2CDB&author=Aronne%2CLJ&author=Wharton%2CS) Nature Medicine (_Nat Med_) ISSN 1546-170X (online) ISSN 1078-8956 (print) ## nature.com footer links ### About Nature Portfolio * [About us](https://www.nature.com/npg_/compa
## Related Clinical Research

- [Lifestyle Changes May Help Prevent Multimorbidity In Prediabetes](https://medichelpline.com/clinical-feed/medical-news-today-23-diet-weight-loss-and-150-minutes-of-exercise-may-protect-against-chronic.md)
- [Semaglutide plus menopause hormone therapy linked to greater weight loss in midlife women](https://medichelpline.com/clinical-feed/medical-news-today-0-ozempic-plus-hormone-therapy-may-help-boost-weight-loss-at-menopause.md)
- [ENDO 2026: Progress and Resilience in Endocrinology and Obesity Care](https://medichelpline.com/clinical-feed/endocrine-news-0-endo-2026-progress-and-resilience.md)
- [Genetic and sociodemographic factors associated with trajectories of physical and mental health multimorbidity in a South Asian cohort in the UK: A multistate modelling analysis](https://medichelpline.com/clinical-feed/plos-medicine-2-genetic-and-sociodemographic-factors-associated-with-trajectories-of-physical.md)
- [Testosterone Therapy in Men Often Prescribed Inconsistently with Guidelines, ENDO 2026 Study Shows](https://medichelpline.com/clinical-feed/endocrine-news-0-video-testosterone-therapy-in-men-may-be-overprescribed-inconsistent-with.md)

## Navigation
- [← Back to Pediatrics Feed](https://medichelpline.com/clinical-feed/pediatrics.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.